share_log

德琪醫藥-B：截至2023年12月31日止月份之股份發行人的證券變動月報表

ANTENGENE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023

香港交易所 ·  Jan 4 03:25
Summary by Moomoo AI
德琪醫藥有限公司於2024年1月4日向香港交易及結算所有限公司提交了截至2023年12月31日的證券變動月報表。報告顯示，公司的法定/註冊股本維持不變，上月底及本月底結存均為2,000,000,000股，每股面值0.0001美元，總額200,000美元。此外，公司的2019及2020股權激勵計劃中，分別有114,180股和61,600股股份期權被註銷。經註銷後，2019股權激勵計劃及2020股權激勵計劃的股份期權結存數目分別為15,986,046股和16,470,220股。本月內沒有因行使期權而得到的資金。報告中未提及有關香港預託證券的資料。
德琪醫藥有限公司於2024年1月4日向香港交易及結算所有限公司提交了截至2023年12月31日的證券變動月報表。報告顯示，公司的法定/註冊股本維持不變，上月底及本月底結存均為2,000,000,000股，每股面值0.0001美元，總額200,000美元。此外，公司的2019及2020股權激勵計劃中，分別有114,180股和61,600股股份期權被註銷。經註銷後，2019股權激勵計劃及2020股權激勵計劃的股份期權結存數目分別為15,986,046股和16,470,220股。本月內沒有因行使期權而得到的資金。報告中未提及有關香港預託證券的資料。
DEKI PHARMACEUTICAL CO., LTD. FILED WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON 4 JANUARY 2024 THE REPORT ON CHANGES IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2023. The report shows that the company's regulated/registered share capital remained unchanged, with 2,000,000,000 shares outstanding at the end of last month and at the end of this month, with a face value of $0.0001 per share for a total amount of $200,000. In addition, 114,180 share and 61,600 share options were written off in the Company's 2019 and 2020 Equity Incentive Programs. After the delisting, the number of stock option deposits under the 2019 Stock Incentive Plan and the 2020 Stock Incentive Plan were 15,986,046 shares and 16,470,220 shares, respectively. No funds received during this month as a result of exercising options. No information on Hong Kong pre-trust securities is mentioned in the report.
DEKI PHARMACEUTICAL CO., LTD. FILED WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON 4 JANUARY 2024 THE REPORT ON CHANGES IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2023. The report shows that the company's regulated/registered share capital remained unchanged, with 2,000,000,000 shares outstanding at the end of last month and at the end of this month, with a face value of $0.0001 per share for a total amount of $200,000. In addition, 114,180 share and 61,600 share options were written off in the Company's 2019 and 2020 Equity Incentive Programs. After the delisting, the number of stock option deposits under the 2019 Stock Incentive Plan and the 2020 Stock Incentive Plan were 15,986,046 shares and 16,470,220 shares, respectively. No funds received during this month as a result of exercising options. No information on Hong Kong pre-trust securities is mentioned in the report.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more